Home › Funds › MPM BioImpact LLC › ORIC

MPM BioImpact LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

MPM BioImpact LLC reported holding 1,882,162 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$20.4M, representing 1.24% of its reported portfolio and ranking #30 among its reported holdings. MPM BioImpact LLC has disclosed ORIC holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.88M sh
Reported value held$20.38M
Portfolio Weight1.24%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's ORIC position evolved

MPM BioImpact LLC first disclosed a stake in ORIC in Q1 2025 at 1,399,514 shares (US$7.8M). The position peaked in Q1 2026 at 1,803,945 shares, worth US$22.9M. Across 6 filings, MPM BioImpact LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,882,162 shares valued at US$20.4M — an increase of 78,217 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.40M $7.81M New
Q2 2025 1.73M $17.55M Add
Q3 2025 1.73M $20.75M Hold
Q4 2025 1.80M $14.71M Add
Q1 2026 1.80M $22.86M Hold
Q2 2026 1.88M $20.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has MPM BioImpact LLC held ORIC?

MPM BioImpact LLC has disclosed ORIC holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is MPM BioImpact LLC's current position in ORIC?

As of Q2 2026, MPM BioImpact LLC holds 1.88M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $20.38M, representing 1.24% of its reported portfolio and ranking #30.

Has MPM BioImpact LLC been buying or selling ORIC?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC increased its position in ORIC. The position peaked in Q1 2026 at 1.80M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.